Induced Pluripotent Stem Cells Generated Without Viral Integration
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome-integrating viruses. We generated mouse induced pluripotent stem (iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc. These adenoviral iPS (adeno-iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient-specific stem cells and for comparing embryonic stem cells and iPS cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24,25,26,27,28].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationReprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
Dissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O., & Jaenisch, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801677105 · Cited by 1,216
Research works printed but not linked: 1
- S. Eminli J. Utikal K. Arnold R. Jaenisch K. Hochedlinger Stem Cells published online 17June2008 in press.
Cited by
Items 501–600 of 1,002
Cell-based therapies for Parkinson’s disease
Dyson, S. C., & Barker, R. A. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.33 · Cited by 43
Smooth Muscle and Other Cell Sources for Human Blood Vessel Engineering
Sundaram, S., & Niklason, L. E. (2011) · Cells Tissues Organs · doi:10.1159/000331409 · Cited by 43
Inducible pluripotent stem cells: not quite ready for prime time?
Robbins, R. D., Prasain, N., Maier, B. F., Yöder, M. C., & Mirmira, R. G. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283337196 · Cited by 43
Induced pluripotent stem cells from goat fibroblasts
Song, H., Li, H., Huang, M., Xu, D., Gu, C., Wang, Z., Dong, F., & Wang, F. (2013) · Molecular Reproduction and Development · doi:10.1002/mrd.22266 · Cited by 43
Talluri, T. R., Kumar, D., Glage, S., Garrels, W., Ivics, Z., Debowski, K., Behr, R., & Kues, W. A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.014 · Cited by 43
Zhang, D., Efendić, S., Brismar, K., & Gu, H. F. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-116 · Cited by 43
Incorporating Existing Network Information into Gene Network Inference
Christley, S., Nie, Q., & Xie, X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006799 · Cited by 42
Cao, X., Deng, W., Qu, R., Yu, Q., Li, J., Yang, Y., Cao, Y., Gao, X., Xu, X., & Yu, J. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201203646 · Cited by 42
Modeling Huntington׳s disease with patient-derived neurons
Mattis, V. B., & Svendsen, C. N. (2015) · Brain Research · doi:10.1016/j.brainres.2015.10.001 · Cited by 42
Stem Cell Therapy: A Prospective Treatment for Alzheimer's Disease
Lee, J. H., Oh, I., & Lim, H. K. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.6.583 · Cited by 42
Induced pluripotent stem cell-based therapy for age-related macular degeneration
Bracha, P., Moore, N. A., & Ciulla, T. A. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1346079 · Cited by 42
KLF4 N-Terminal Variance Modulates Induced Reprogramming to Pluripotency
Kim, S., Oceguera-Yañez, F., Hirohata, R., Linker, S. B., Okita, K., Yamada, Y., Yamamoto, T., Yamanaka, S., & Woltjen, K. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.02.004 · Cited by 42
Pareja, E., Gómez-Lechón, M. J., & Tolosa, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.164 · Cited by 42
Induced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine
Botman, O., & Wyns, C. (2014) · Frontiers in Surgery · doi:10.3389/fsurg.2014.00005 · Cited by 42
Reprogramming antitumor immunity
Crompton, J. G., Clever, D. C., Vizcardo, R., Rao, M. S., & Restifo, N. P. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.003 · Cited by 41
Schönig, K., Bujard, H., & Gossen, M. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)77022-1 · Cited by 41
Induced pluripotent stem cells: paths to new medicines
Deng, W. (2010) · EMBO Reports · doi:10.1038/embor.2010.15 · Cited by 41
Epigenetic foundations of pluripotent stem cells that recapitulate in vivo pluripotency
Yagi, M., Yamanaka, S., & Yamada, Y. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.87 · Cited by 41
Induced pluripotent stem cells: advances to applications
Nelson, T. J., Martinez-Fernandez, A., Yamada, S., Ikeda, Y., Perez-Terzic, C., & Terzic, A. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s4954 · Cited by 41
Induced pluripotent stem cells: origins, applications, and future perspectives
Zhao, J. Y., Jiang, W., Sun, C., Hou, C., Yang, X., & Gao, J. (2013) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300215 · Cited by 41
Cancer stem cell subsets and their relationships
Liu, H., Chen, C., Yang, H., Pan, Y., & Zhang, X. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-50 · Cited by 41
Development of New Technologies for Stem Cell Research
Ma, X., Zhang, Q., Yang, X., & Tian, J. (2012) · BioMed Research International · doi:10.1155/2012/741416 · Cited by 41
Stem cell therapy for glaucoma: Science or snake oil?
Sun, Y., Williams, A. L., Waisbourd, M., Iacovitti, L., & Katz, L. J. (2014) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2014.07.001 · Cited by 41
Peters, A., Burridge, P. W., Pryzhkova, M. V., Levine, M. A., Park, T. S., Roxbury, C. R., Yuan, X., Péault, B., & Zambidis, E. T. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.093043ap · Cited by 41
Zou, X., Yang, H.-Y., Yu, Z., Tan, X., Yan, X., & Huang, G. T. ‐. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt134 · Cited by 41
Stem cell therapy for cardiac disease
Flynn, A. W., & O’Brien, T. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.543894 · Cited by 41
Cell therapy in critical limb ischemia: current developments and future progress
Mamidi, M. K., Pal, R., Dey, S., Abdullah, B. J. J., Zakaria, Z., Rao, M. S., & Das, A. K. (2012) · Cytotherapy · doi:10.3109/14653249.2012.693156 · Cited by 41
Noureini, S. K., & Wink, M. (2014) · Molecules · doi:10.3390/molecules190811846 · Cited by 41
Stanslowsky, N., Haase, A., Martin, U., Naujock, M., Leffler, A., Dengler, R., & Wegner, F. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt423 · Cited by 40
Understanding the roadmaps to induced pluripotency
Liu, K., Song, Y., Yu, H., & Zhao, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.205 · Cited by 40
Lukaszewicz, A. I., McMillan, M., & Kahn, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901361d · Cited by 40
Embryonic Stem Cells and Induced Pluripotent Stem Cells for Skeletal Regeneration
Park, S., & Im, G. (2013) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2013.0530 · Cited by 40
Current Status of Stem Cell Therapy for Liver Diseases
Souza, B. S. D. F., Nogueira, R. C., de Oliveira, S. A., de Freitas, L. A. R., Lyra, L. G. C., dos Santos, R. R., Lyra, A. C., & Soares, M. B. P. (2009) · Cell Transplantation · doi:10.3727/096368909x470522 · Cited by 40
Easley, C. A., Miki, T., Castro, C. A., Ozolek, J. A., Minervini, C. F., Ben‐Yehudah, A., & Schatten, G. P. (2012) · Cellular Reprogramming · doi:10.1089/cell.2011.0106 · Cited by 40
Kang, P. J., Moon, J.-H., Yoon, B. S., Hyeon, S., Jun, E. K., Park, G., Yun, W., Park, J., Park, M., Kim, A., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.015 · Cited by 40
Development of an All-in-One Inducible Lentiviral Vector for Gene Specific Analysis of Reprogramming
Yamaguchi, T., Hamanaka, S., Kamiya, A., Okabe, M., Kawarai, M., Wakiyama, Y., Umino, A., Hayama, T., Sato, H., Lee, Y.-S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041007 · Cited by 39
Sridhar, A., Ohlemacher, S. K., Langer, K. B., & Meyer, J. S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0093 · Cited by 39
The prospect of induced pluripotent stem cells for diabetes mellitus treatment
Soejitno, A., & Prayudi, P. K. A. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811420198 · Cited by 39
Dambrot, C., van de Pas, S., van Zijl, L., Brändl, B., Wang, J., Schalij, M. J., Hoeben, R. C., Atsma, D. E., Mikkers, H. M. M., Mummery, C. L., et al. (2013) · Differentiation · doi:10.1016/j.diff.2013.01.001 · Cited by 39
Modeling Neurological Diseases Using Patient-Derived Induced Pluripotent Stem Cells
Juopperi, T. A., Song, H., & Ming, G.-L. (2011) · Future Neurology · doi:10.2217/fnl.11.14 · Cited by 39
Induced pluripotent stem cell-derived cardiomyocytes as models for genetic cardiovascular disorders
Josowitz, R., Carvajal‐Vergara, X., Lemischka, I. R., & Gelb, B. D. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834598ad · Cited by 39
Mormone, E., D'Sousa, S., Alexeeva, V., Bederson, M. M., & Germano, I. M. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0151 · Cited by 39
Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
Tousley, A. R., & Kegel-Gleason, K. B. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160199 · Cited by 39
An introduction to induced pluripotent stem cells
Hanley, J., Rastegarlari, G., & Nathwani, A. C. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08296.x · Cited by 39
Lu, H.-E., Tsai, M., Yang, Y.-C., Yuan, C.-C., Wang, T., Lin, X., Tseng, C., & Hwang, S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.05.017 · Cited by 39
Prospects of Induced Pluripotent Stem Cell Technology in Regenerative Medicine
Zhang, F., Citra, F., & Wang, D. (2011) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2010.0549 · Cited by 39
Steinle, H., Weber, M., Behring, A., Mau-Holzmann, U. A., Schlensak, C., Wendel, H. P., & Avci‐Adali, M. (2019) · Stem Cells International · doi:10.1155/2019/7641767 · Cited by 39
Differentiation of Stem Cells into Insulin-Producing Cells: Current Status and Challenges
Pokrywczyńska, M., Krzyzanowska, S., Jundziłł, A., Adamowicz, J., & Drewa, T. A. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0213-y · Cited by 39
Wong, G. K. Y., & Chiu, A. T. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.07.005 · Cited by 39
Imaizumi, M., Nomoto, Y., Sato, Y., Sugino, T., Miyake, M., Wada, I., Nakamura, T., & Omori, K. (2013) · Cell Transplantation · doi:10.3727/096368912x653147 · Cited by 39
Chemical approaches to studying stem cell biology
Li, W., Jiang, K., Wei, W., Shi, Y., & Ding, S. (2012) · Cell Research · doi:10.1038/cr.2012.182 · Cited by 39
Sox2 Transduction Enhances Cardiovascular Repair Capacity of Blood-Derived Mesoangioblasts
Koyanagi, M., Iwasaki, M., Rupp, S., Tedesco, F. S., Yoon, C., Boeckel, J., Trauth, J., Schütz, C., Ohtani, K., Goetz, R., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.206045 · Cited by 39
Patient-specific pluripotent stem cells: promises and challenges
Müller, R., & Lengerke, C. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.18 · Cited by 39
Induced Pluripotent Stem (iPS) Cell Research Overview
Liu, S., Fu, R., Huang, Y.-C., Chen, S.-Y., Chien, Y.-J., Hsu, C. Y., Tsai, C., Shyu, W., & Lin, S. (2011) · Cell Transplantation · doi:10.3727/096368910x532828 · Cited by 39
A computer-guided design tool to increase the efficiency of cellular conversions
Jung, S., Appleton, E., Ali, M., Church, G. M., & del Sol, A. (2021) · Nature Communications · doi:10.1038/s41467-021-21801-4 · Cited by 38
Zhang, M., Wang, L., An, K., Cai, J., Li, G., Yang, C., Liu, H., Du, F., Han, X., Zhang, Z., et al. (2018) · Cancer Communications · doi:10.1186/s40880-018-0313-0 · Cited by 38
Returning to the stem state: Epigenetics of recapitulating pre‐differentiation chromatin structure
Shafa, M., Krawetz, R. J., & Rancourt, D. E. (2010) · BioEssays · doi:10.1002/bies.201000033 · Cited by 38
Clinical potential of human-induced pluripotent stem cells
Kumar, D., Anand, T., & Kues, W. A. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9370-9 · Cited by 38
Li, W., Chen, S., & Li, J. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.009 · Cited by 38
Regenerative Cell Therapy for Corneal Endothelium
Bartáková, A., Kunzevitzky, N. J., & Goldberg, J. L. (2014) · Current Ophthalmology Reports · doi:10.1007/s40135-014-0043-7 · Cited by 38
Challenges of using pluripotent stem cells for safety assessments of substances
Vojnits, K., & Bremer, S. (2009) · Toxicology · doi:10.1016/j.tox.2009.12.003 · Cited by 38
Mastromonaco, G. F., González-Grajales, L. A., Filice, M., & Comizzoli, P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0820-2_16 · Cited by 38
Soares, F. A. C., Sheldon, M., Rao, M., Mummery, C., & Vallier, L. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.11.006 · Cited by 37
Current progress and prospects of induced pluripotent stem cells
Chen, L., & Liu, L. (2009) · Science in China Series C Life Sciences · doi:10.1007/s11427-009-0092-6 · Cited by 37
Breckwoldt, K., Weinberger, F., & Eschenhagen, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.010 · Cited by 37
Okumura, T., Horie, Y., Lai, C.-Y., Lin, H.-T., Shoda, H., Natsumoto, B., Fujio, K., Kumaki, E., Okano, T., Ono, S., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1273-2 · Cited by 37
Human Stem Cells and Articular Cartilage Regeneration
Inui, A., Iwakura, T., & Reddi, A. H. (2012) · Cells · doi:10.3390/cells1040994 · Cited by 37
Smith, D. K., He, M., Zhang, C., & Zheng, J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.006 · Cited by 37
Akıncılar, S. C., Chua, J. Y. H., Ng, Q. F., Chan, C. H. T., Eslami‐S, Z., Chen, K., Low, J.-L., Arumugam, S., Aswad, L., Chua, C., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac479 · Cited by 37
Conversion of Ancestral Fibroblasts to Induced Pluripotent Stem Cells
Araki, R., Jincho, Y., Hoki, Y., Nakamura, M., Tamura, C., Ando, S., Kasama, Y., & Abe, M. (2009) · Stem Cells · doi:10.1002/stem.282 · Cited by 37
Embryonic Stem Cells and iPS Cells: Sources and Characteristics
Hackett, C. H., & Fortier, L. A. (2011) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2011.04.003 · Cited by 37
Cell‐free production of transducible transcription factors for nuclear reprogramming
Yang, W. C., Patel, K. G., Lee, J., Ghebremariam, Y. T., Wong, H. E., Cooke, J. P., & Swartz, J. R. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22517 · Cited by 37
Kim, E., Manzar, G. S., & Zavazava, N. (2013) · Blood · doi:10.1182/blood-2012-11-467753 · Cited by 37
iPSCs, aging and age-related diseases
Isobe, K., Cheng, Z., Nishio, N., Thanasegaran, S., Tanaka, Y., & Ito, S. (2014) · New Biotechnology · doi:10.1016/j.nbt.2014.04.004 · Cited by 36
Modeling blood diseases with human induced pluripotent stem cells
Georgomanoli, M., & Papapetrou, E. P. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039321 · Cited by 36
Prasad, A., Manivannan, J., Loong, D. T., Chua, S. M., Gharibani, P. M., & All, A. H. (2016) · Regenerative Medicine · doi:10.2217/rme.16.5 · Cited by 36
Induced Pluripotent Stem Cells in Dermatology: Potentials, Advances, and Limitations
Bilousova, G., & Roop, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015164 · Cited by 36
10th anniversary of iPS cells: the challenges that lie ahead
Aoi, T. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw044 · Cited by 36
Programmable genetic switches to control transcriptional machinery of pluripotency
Pandian, G. N., & Sugiyama, H. (2012) · Biotechnology Journal · doi:10.1002/biot.201100361 · Cited by 36
Thinking outside the liver: Induced pluripotent stem cells for hepatic applications
Rao, M. S., Sasikala, M., & Reddy, D. N. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i22.3385 · Cited by 36
Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications
Staal, F. J. T., Baum, C., Cowan, C. A., Dzierzak, E. A., Hacein‐Bey‐Abina, S., Karlsson, S., Lapidot, T., Lemischka, I. R., Méndez‐Ferrer, S., Mikkers, H. M. M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.52 · Cited by 36
Partial Somatic to Stem Cell Transformations Induced By Cell-Permeable Reprogramming Factors
Lim, J., Kim, J., Kang, J., & Jo, D. (2014) · Scientific Reports · doi:10.1038/srep04361 · Cited by 36
Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
“Adenovirus and Sendai virus-mediated vector delivery provide alternative non-integrative methods for iPSC reprogramming [24–28].”
Generation of human induced pluripotent stem cells using non-synthetic mRNA
Rohani, L., Fabian, C., Holland, H., Naaldijk, Y., Dressel, R., Löffler-Wirth, H., Binder, H., Arnold, A., & Stolzing, A. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.03.008 · Cited by 35
Prospects for the manufacture of red cells for transfusion
Mountford, J. C., Olivier, E. N., & Turner, M. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08079.x · Cited by 35
Vascular diseases await translation of blood vessels engineered from stem cells
Samuel, R., Duda, D. G., Fukumura, D., & Jain, R. K. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1805 · Cited by 35
CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
Chaterji, S., Ahn, E. H., & Kim, D.-H. (2017) · Theranostics · doi:10.7150/thno.18456 · Cited by 35
Cell Therapy Approaches for Articular Cartilage Regeneration
Makarczyk, M. J. (2023) · Organogenesis · doi:10.1080/15476278.2023.2278235 · Cited by 35
Efficient Generation of Nonhuman Primate Induced Pluripotent Stem Cells
Zhong, B., Trobridge, G. D., Zhang, X., Watts, K. L., Ramakrishnan, A., Wohlfahrt, M. E., Adair, J. E., & Kiem, H. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0343 · Cited by 35
Hu, W., He, Y., Xiong, Y., Lu, H., Chen, H., Hou, L., Qiu, Z., Yu, F., & Zhang, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9084-z · Cited by 35
Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases
Shi, L., Cui, Y., Luan, J. Y., Zhou, X., & Han, J. (2016) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2016.01062 · Cited by 35
Small Molecules in Cellular Reprogramming and Differentiation
Xu, Y., Li, W., & Ding, S. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_13 · Cited by 35
Induction of retinal ganglion-like cells from fibroblasts by adenoviral gene delivery
Meng, F., Wang, X., Gu, P., Wang, Z., & Guo, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.001 · Cited by 34
On the Road to iPS Cell Cardiovascular Applications
Kamp, T. J., & Lyons, G. E. (2009) · Circulation Research · doi:10.1161/circresaha.109.205740 · Cited by 34
Nicoleau, C., Viegas, P., Peschanski, M., & Perrier, A. L. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0079-4 · Cited by 34
Generation of Induced Pluripotent Stem Cells from Somatic Cells
Sohn, Y.-D., Han, J. W., & Yoon, Y. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-398459-3.00001-0 · Cited by 34
Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals
Talón, I., Janiszewski, A., Theeuwes, B., Lefevre, T., Song, J., Bervoets, G., Vanheer, L., Geest, N. D., Poovathingal, S. K., Allsop, R., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02518-5 · Cited by 34
Induced Pluripotent Stem Cell Technology: Trends in Molecular Biology, from Genetics to Epigenetics
Maali, A., Maroufi, F., Sadeghi, F., Atashi, A., Kouchaki, R., Moghadami, M., & Azad, M. (2021) · Epigenomics · doi:10.2217/epi-2020-0409 · Cited by 34
Fernandez, T. D. S., Fernandez, C. D. S., & Mencalha, A. L. (2013) · BioMed Research International · doi:10.1155/2013/430290 · Cited by 34
Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders
Wang, H., & Doering, L. C. (2012) · Neural Plasticity · doi:10.1155/2012/346053 · Cited by 34
Metadata
- Authors
- Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- Hochedlinger, Konrad
- Venue
- Science
- Published
- 2008-11-07
- Volume
- 322
- Issue
- 5903
- Pages
- 945-949
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3987909
- OpenAlex
- W2050689355
- Cited by
- 1,683
- References
- 29
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 33 · 2023: 22 · 2022: 32 · 2021: 55 · 2020: 50 · 2019: 38 · 2018: 63 · 2017: 63 · 2016: 104 · 2015: 105 · 2014: 139 · 2013: 161 · 2012: 185
- FWCI
- 82.28
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1dp2od003266-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, Oct4, SOX2, KLF4, c-Myc, somatic cell reprogramming, DNA demethylation, teratoma, chimeric mice, fibroblasts, hepatocytes, insertional mutagenesis, patient-derived stem cells, embryonic stem cells
- MeSH terms
- Kruppel-Like Factor 4, Adenoviridae, Animals, Cell Differentiation, Cell Line, Chimera, Cloning, Molecular, Female, Fibroblasts, Genetic Vectors, Liver, Male, Teratoma, Genes, myc, Proto-Oncogene Proteins c-myc, Mice, SCID, Virus Integration, Transgenes, Hepatocytes, Pluripotent Stem Cells, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.